Association of oxidative stress to the genesis of anxiety: Implications for possible therapeutic interventions

Current Neuropharmacology

Volumn 12, Issue 2, 2014, Pages 120-139

  Hassan, Waseem ^a,b   Silva, Carlos Eduardo Barroso ^a   Mohammadzai, Imdad Ullah ^b   da Rocha, Joao Batista Teixeira ^c   Landeira Fernandez, J ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF PESHAWAR   (Pakistan)

^c FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Antioxidant therapy; Anxiety disorders; Oxidative stress; Toxicity

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ALPHA TOCOPHEROL; ANTIDEPRESSANT AGENT; ANTIOXIDANT; ANXIOLYTIC AGENT; APIGENIN; ASCORBIC ACID; CAFFEIC ACID; CATALASE; CHLOROGENIC ACID; EPIGALLOCATECHIN GALLATE; FREE RADICAL; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTOYLGLUTATHIONE LYASE; METAL; METHYLGLYOXAL; MOOD STABILIZER; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROTRANSMITTER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; QUERCETIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; ROSMARINIC ACID; RUTOSIDE; SUPEROXIDE DISMUTASE; TETRAGASTRIN; UNINDEXED DRUG;

ANXIETY; ANXIETY DISORDER; ARTICLE; DEPRESSION; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; OXIDATIVE STRESS; PANIC; PHOBIA; POSTTRAUMATIC STRESS DISORDER;

EID: 84984577430     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X11666131120232135     Document Type: Article

References (230)

1. Inoue, M.; Sato, E.F.; Nishikawa, M.; Park, A.M.; Kira, Y.; Imada, I.; Utsumi, K. Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr. Med. Chem. 2003, 10, 2495-2505. http://dx.doi.org/10.2174/0929867033456477
2. Bergendi, L.; Benes, L.; Duracková, Z.; Ferencik, M. Chemistry, physiology and pathology of free radicals. Life Sci. 1999, 65, 1865-1874. http://dx.doi.org/10.1016/S0024-3205(99)00439-7
3. Valko, M.; Izakovic, M.; Mazur, M.; Rhodes C.J.; Telser, J. Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cell. Biochem. 2004, 266, 37-56. http://dx.doi.org/10.1023/B:MCBI.0000049134.69131.89
4. Gupta, M.; Dobashi, K.; Greene, E.L.; Orak, J.K.; Singh, I. Studies on hepatic injury and antioxidant enzyme activities in rat subcellular organelles following in vivo ischemia and reperfusion. Mol. Cell. Biochem. 1997, 176, 337-347. http://dx.doi.org/10.1007/978-1-4615-5765-4_42
5. Stamler, J.S.; Simon, D.I.; Osborne, J.A.; Mullins, M.E.; Jaraki, O.; Michel, T.; Singel, D.J.; Loscalzo, J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. U. S. A. 1992, 89, 444-448. http://dx.doi.org/10.1073/pnas.89.1.444
6. Pastor, N.; Weinstein, H.; Jamison, E.; Brenowitz, M. Detailed interpretation of OH radical footprints in a TBP-DNA complex reveals the role of dynamics in the mechanism of sequence-specific binding. J. Mol. Biol. 2000, 304, 55-68. http://dx.doi.org/10.1006/jmbi.2000.4173
7. Archer, S. Measurement of nitric oxide in biological models. FASEB J. 1993, 7, 349-360. PMID: 8440411
8. Alderton, W.K.; Cooper, C.E.; Knowles, R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 2001, 357, 593-615. PMID: 11463332
9. Ghafourifar, P.; Cadenas, E. Mitochondrial nitric oxide synthase. Trends Pharmacol. Sci. 2005, 26, 190-195. http://dx.doi.org/10.1016/j.tips.2005.02.005
10. Ridnour, L.A.; Thomas, D.D.; Mancardi, D.; Miranda, K.M.; Paolocci, N.; Feelisch, M.; Fukuto, J.; Wink, D.A. The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species: putting perspective on stressful biological situations. Biol. Chem. 2004, 385, 10. http://dx.doi.org/10.1515/BC.2004.001
11. Valko, M.; Morris, H.; Cronin, M.T.D. Met-aletal/et-als, toxicity and oxidative stress. Curr. Med. Chem. 2005, 12, 1161-1208. http://dx.doi.org/10.2174/0929867053764635
12. Farina, M.; Avila, D.S.; da Rocha, J.B.; Aschner, M. Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury. Neurochem. Int. 2013, 62, 575-594. http://dx.doi.org/10.1016/j.neuint.2012.12.006
13. Welch, S. A comparison of the structure and properties of serum transferrin from 17 animal species. Comp. Biochem. Physiol. B 1990, 97, 417-427. http://dx.doi.org/10.1016/0305-0491(90)90138-J
14. Sipe, D.M.; Murphy, R.F. Binding to cellular receptors results in increased iron release from transferrin at mildly acidic pH. J. Biol. Chem., 1991, 266, 8002-8007. PMID:2022630
15. Pederson, T.C.; Buege, J.A.; Aust, S.D. Microsomal electron transport: the role of reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase in liver microsomal lipid peroxidation. J. Biol. Chem. 1973, 248, 7134-7141.PMID: 4200585
16. Matés, J.M.; Pérez-Gómez, C.; Núñez de Castro, I.N. Antioxidant enzymes and human diseases. Clin. Biochem. 1999, 32, 595-603. http://dx.doi.org/10.1016/S0009-9120(99)00075-2
17. McCall, M.R.; Frei, B. Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic. Biol. Med. 1999, 26, 1034-1053. http://dx.doi.org/10.1016/S0891-5849(98)00302-5
18. Andersen, J.K. Oxidative stress in neurodegeneration: cause or consequence? Nat. Rev. Neurosci. 2004, 5, S18-S25.PMID: 15298006
19. Dean, O.M.; van den Buuse, M.; Bush, A.I.; Copolov, D.L.; Ng, F.; Dodd, S.; Berk, M. A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice. Curr. Med. Chem. 2009, 16, 2965-2976. http://dx.doi.org/10.2174/092986709788803060
20. Liu, C.F.; Yu, L.F.; Lin, C.H.; Lin, S.C. Effect of auricular pellet acupressure on antioxidative systems in high-risk diabetes mellitus. J. Altern. Complement. Med. 2008, 14, 303-307. http://dx.doi.org/10.1089/acm.2006.6064
21. Hovatta, I.; Juhila, J.; Donner, J. Oxidative stress in anxiety and comorbid disorders. Neurosci. Res. 2010, 68, 261-275. http://dx.doi.org/10.1016/j.neures.2010.08.007
22. Gaeta, A.; Hider, R.C. The crucial role of metal ions in neuro-degeneration: the basis for a promising therapeutic strategy. Br. J. Pharmacol. 2005, 146, 1041-1059. 10.1038/sj.bjp.0706416
23. Berry, A.; Capone, F.; Giorgio, M.; Pelicci, P.G.; de Kloet, E.R.; Alleva, E.; Minghetti, L.; Cirulli, F. Deletion of the life span determinant p66Shc prevents age-dependent increases in emotionality and pain sensitivity in mice. Exp. Gerontol. 2007, 42, 37-45. http://dx.doi.org/10.1016/j.exger.2006.05.018
24. Desrumaux, C.; Risold, P.Y.; Schroeder, H.; Deckert, V.; Masson D.; Athias, A.; Laplanche, H.; Le Guern, N.; Blache, D.; Jiang, X.C.; Tall, A.R.; Desor, D.; Lagrost, L. Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice. FASEB J. 2005, 19, 296-297. http://dx.doi.org/10.1096/fj.04-2400fje
25. Bouayed, J.; Rammal, H.; Younos, C.; Soulimani, R. Positive correlation between peripheral blood granulocyte oxidative status and level of anxiety In mice. Eur. J. Pharmacol. 2007, 564, 146-149. http://dx.doi.org/10.1016/j.ejphar.2007.02.055
26. de Oliveira, M.R.; Silvestrin, R.B.; Mello e Souza, T.; Moreira, J.C. Oxidative stress in the hippocampus, anxiety-like behavior and decreased locomotory and exploratory activity of adult rats: effects of sub acute vitamin A supplementation at therapeutic doses. Neurotoxicology 2007, 6, 1191-1199. http://dx.doi.org/10.1016/j.neuro.2007.07.008
27. Salim, S.; Sarraj, N.; Taneja, M.; Saha, K.; Tejada-Simon, M.V.; Chugh, G. Moderate treadmill exercise prevents oxidative stress-induced anxiety-like behavior in rats. Behav. Brain Res. 2010, 208, 545-552. http://dx.doi.org/10.1016/j.bbr.2009.12.039
28. Salim, S.; Asghar, M.; Chugh, G.; Taneja, M.; Xia, Z.; Saha, K. Oxidative stress: a potential recipe for anxiety, hypertension and insulin resistance. Brain Res. 2010, 1359, 178-185. http://dx.doi.org/10.1016/j.brainres.2010.08.093
29. Souza, C.G.; Moreira, J.D.; Siqueira, I.R.; Pereira, A.G.; Rieger, D.K.; Souza, D.O.; Souza, T.M.; Portela, L.V.; Perry, M.L. Highly palatable diet consumption increases protein oxidation in rat frontal cortex and anxiety-like behavior. Life Sci. 2007, 81, 198-203. http://dx.doi.org/10.1016/j.lfs.2007.05.001
30. Masood, A.; Nadeem, A.; Mustafa, S.J.; O'Donnell, J.M. Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. J. Pharmacol. Exp. Ther. 2008, 326, 369-379. http://dx.doi.org/10.1124/jpet.108.137208
31. Rammal, H.; Bouayed, J.; Younos, C.; Soulimani, R. The impact of high anxiety levels on the oxidative status of mouse peripheral blood lymphocytes, granulocytes and monocytes. Eur. J. Pharmacol. 2008, 589, 173-175. http://dx.doi.org/10.1016/j.ejphar.2008.06.053
32. Kuloglu, M.; Atmaca, M.; Tezcan, E.; Gecici, O.; Tunckol, H.; Ustundag, B. Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder. Neuro-psychobiology 2002, 46, 27-32. http://dx.doi.org/10.1159/000063573
33. Kuloglu, M.; Atmaca, M.; Tezcan, E.; Gecici, O.; Ustundag, B.; Bulut, S. Antioxidant enzyme and malondialdehyde levels in patients with panic disorder. Neuropsychobiology 2002, 46, 186-189. http://dx.doi.org/10.1159/000067810
34. Yasunari, K.; Matsui, T.; Maeda, K.; Nakamura, M.; Watanabe, T.; Kiriike, N. Anxiety-induced plasma norepinephrine augmentation increases reactive oxygen species formation by monocytes in essential hypertension. Am. J. Hypertens. 2006, 19, 573-578. DOI: 10.1016/j.amjhyper.2005.10.027
35. Pandey, K.B.; Rizvi, S.I. Markers of oxidative stress in erythrocytes and plasma during aging in humans. Oxid. Med. Cell. Longev. 2010, 3, 2-12. http://dx.doi.org/10.4161/oxim.3.1.10476
36. Ko, S.H.; Cao, W.; Liu, Z. Hypertension management and micro-vascular insulin resistance in diabetes. Curr. Hypertens. Rep. 2010, 12, 243-251.
37. Salustri, C.; Squitti, R.; Zappasodi, F.; Ventriglia, M.; Bevacqua, M.G.; Fontana, M.; Tecchio, F. Oxidative stress and brain glutamate-mediated excitability in depressed patients. J. Affect. Disord. 2010, 127, 321-325. http://dx.doi.org/10.1016/j.jad.2010.05.012
38. Castro-Gomes, V.; Landeira-Fernandez, J. Amygdaloid lesions produced similar contextual fear conditioning disruption in the Carioca high- and low-conditioned freezing rats. Brain Res. 2008, 1233, 137-145. http://dx.doi.org/10.1016/j.brainres.2008.07.044
39. Landeira-Fernandez, J. Context and Pavlovian conditioning. Braz. J. Med. Biol. Res. 1996, 29, 149-173. PubMed ID: 8731345
40. Pavlov, I. Conditioned Reflexes: An Investigation of the Physiological Activity of the Cerebral Cortex. Oxford University Press, London. 1927. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC407804
41. Hassan, W.; Gomes, V.C.; Pinton, S.; Rocha, J.B.T.; Landeira-Fernandez, J. Association between oxidative stress and contextual fear conditioning in Carioca high- and low-conditioned freezing rats. Brain Res. 2013, in press.PMID: 23566816
42. Bonatto, F.; Polydoro, M.; Andrades, M.E.; Frota, M.L.C., Jr.; Dal-Pizzol, F.; Rotta, L.N.; Souza, D.O.; Perry, M.L.; Moreira, J.C. Effect of protein malnutrition on redox state of the hippocampus of rat. Brain Res. 2005, 1042, 17-22. http://dx.doi.org/10.1016/j.brainres.2005.02.002
43. Gabbita, S.P.; Lovell, M.A.; Markesbery, W.R. Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J. Neurochem. 1998, 71, 2034-2040. http://dx.doi.org/10.1046/j.1471-4159.1998.71052034.x
44. Serrano, F.; Klann, E. Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Res. Rev. 2004, 3, 431-443. http://dx.doi.org/10.1016/j.arr.2004.05.002
45. Allam, F.; Dao, A.T.; Chugh, G.; Bohat, R.; Jafri, F.; Patki, G.; Mowrey, C.; Asghar, M.; Alkadhi, K.A.; Salim, S. Grape powder supplementation prevents oxidative stress-induced anxiety-like behavior, memory impairment, and high blood pressure in rats. J. Nutr. 2013, in press. http://www.ncbi.nlm.nih.gov/pubmed/23596160
46. Butterfield, D.A.; Reed, T.; Perluigi, M.; De Marco, C.; Coccia, R.; Cini, C.; Sultana, R. Elevated protein-bound levels of the lipid peroxidation product 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci. Lett. 2006, 397, 170-173. http://dx.doi.org/10.1016/j.neulet.2005.12.017
47. Rogers, J.L.; Hunsaker, M.R.; Kesner, R.P. Effects of ventral and dorsal CA1 subregional lesions on trace fear conditioning. Neurobiol. Learn. Mem. 2006, 86, 72-81. http://dx.doi.org/10.1016/j.nlm.2006.01.002
48. Yoon, T.; Otto T. Differential contributions of dorsal vs. ventral hippocampus to auditory trace fear conditioning. Neurobiol. Learn. Mem. 2007, 87, 464-475. http://dx.doi.org/10.1016/j.nlm.2006.12.006
49. Dias, G.P.; Bevilaqua, M.C.; Silveira, A.C.; Landeira-Fernandez, J.; Gardino, P.F. Behavioral profile and dorsal hippocampal cells in Carioca high-conditioned freezing rats. Behav. Brain Res. 2009, 205, 342-348. http://dx.doi.org/10.1016/j.bbr.2009.06.038
50. Fujimoto, M.; Uchida, S.; Watanuki, T.; Wakabayashi, Y.; Otsuki, K.; Matsubara, T.; Suetsugi, M.; Funato, H.; Watanabe, Y. Reduced expression of glyoxalase-1 mRNA in mood disorder patients. Neurosci. Lett. 2008, 438, 196-199. http://dx.doi.org/10.1016/j.neulet.2008.04.024
51. Arai, M.; Yuzawa, H.; Nohara, I.; Ohnishi, T.; Obata, N., Iwayama, Y.; Haga, S.; Toyota, T.; Ujike, H.; Arai, M.; Ichikawa, T.; Nishida, A.; Tanaka, Y.; Furukawa, A.; Aikawa, Y.; Kuroda, O.; Niizato, K.; Izawa, R.; Nakamura, K.; Mori, N.; Matszawa, D.; Hashimoto, K.; Iyo, M.; Sora, I.; Matsushita, M.; Okazaki, Y.; Yoshikawa, T.; Miyata, T.; Itokawa, M. Enhanced carbonyl stress in a subpopulation of schizophrenia. Arch. Gen. Psychiatry 2010, 67, 589-597. 10.1001/archgenpsychiatry.2010.62
52. Toyosima, M.; Maekawa, M.; Toyota, T.; Iwayama, Y.; Arai, M.; Ichikawa, T.; Miyashita, M.; Arinami, T.; Itokawa, M.; Yoshikawa, T. Schizophrenia with the 22q11. 2 deletion and additional genetic defects: case history. Br. J. Psychiatry 2010, 199, 245-246. http://dx.doi.org/10.1192/bjp.bp.111.093849
53. Politi, P.; Minoretti, P.; Falcone, C.; Martinelli, V.; Emanuele, E. Association analysis of the functional Ala111Glu polymorphism of the glyoxalase I gene in panic disorder. Neurosci. Lett. 2006, 396, 163-166. http://dx.doi.org/10.1016/j.neulet.2005.11.028
54. Junaid, M.A.; Kowal, D., Barua, M.; Pullarkat, P.S.; Sklower Brooks, S.; Pullarkat, R.K. Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. Am. J. Med. Genet. A 2004, 131, 11-17. http://dx.doi.org/10.1002/ajmg.a.30349
55. Barua, M.; Jenkins, E.C.; Chen, W.; Kuizon, S.; Pullarkat, R.K.; Junaid, M.A. Glyoxalase I polymorphism rs2736654 causing the Ala111Glu substitution modulates enzyme activity: implications for autism. Autism Res. 2011, 4, 262-270. http://dx.doi.org/10.1002/aur.197
56. Stefansson, H.; Rye, D.B.; Hicks, A.; Petursson, H.; Ingason, A.; Thorgeirsson, T.E.; Palsson, S.; Sigmundsson, T.; Sigurdsson, A.P.; Eiriksdottir, I.; Soebech, E.; Bliwise, D.; Beck, J.M.; Rosen, A.; Waddy, S.; Trotti, L.M.; Iranzo, A.; Thambisetty, M.; Hardarson, G.A.; Kristjansson, K.; Gudmundsson, L.J.; Thorsteinsdottir, U.; Kong, A.; Gulcher, J.R.; Gudbjartsson, D.; Stefansson, K. A genetic risk factor for periodic limb movements in sleep. N. Engl. J. Med. 2007, 357, 639-647. http://dx.doi.org/10.1056/NEJMoa072743
57. Winkelmann, J.; Schormair, B.; Lichtner, P.; Ripke, S.; Xiong, L.; Jalilzadeh, S.; Fulda, S.; Pütz, B.; Eckstein, G.; Hauk, S.; Trenkwalder, C.; Zimprich, A.; Stiasny-Kolster, K.; Oertel, W.; Bachmann, C.G.; Paulus, W.; Peglau, I.; Eisensehr, I.; Montplaisir, J.; Turecki, G.; Rouleau, G.; Gieger, C.; Illig, T.; Wichmann, H.E.; Holsboer, F.; Müller-Myhsok, B.; Meitinger, T. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat. Genet. 2007, 39, 1000-1006. http://dx.doi.org/10.1038/ng2099
58. Winkelmann, J.; Czamara, D.; Schormair, B.; Knauf, F.; Schulte, E.C.; Trenkwalder, C; Dauvilliers, Y.; Polo, O.; Högl, B.; Berger, K.; Fuhs, A.; Gross, N.; Stiasny-Kolster, K.; Oertel, W.; Bachmann, C.G.; Paulus, W.; Xiong, L.; Montplaisir, J.; Rouleau, G.A.; Fietze, I.; Vávrová, J.; Kemlink, D.; Sonka, K.; Nevsimalova, S.; Lin, S.C.; Wszolek, Z.; Vilariño-Giiell, C; Farrer, M.J.; Gschliesser, V.; Frauscher, B.; Falkenstetter, T.; Poewe, W.; Allen, R.P.; Earley, C.J.; Ondo, W.G.; Le, W.D.; Spieler, D.; Kaffe, M.; Zimprich, A.; Kettunen, J.; Perola, M.; Silander, K.; Cournu-Rebeix, I.; Francavilla, M.; Fontenille, C; Fontaine, B.; Vodicka, P.; Prokisch, H.; Lichtner, P.; Peppard, P.; Faraco, J.; Mignot, E.; Gieger, C; Illig, T.; Wichmann, H.E.; Miiller-Myhsok, B.; Meitinger, T. Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2pl4 and 16ql2.1. PLoS Genet. 2007, 7, el002171. http://dx.doi.org/10.1371/journal.pgen.1002171
59. Kemlink, D.; Polo, O.; Frauscher, B.; Gschliesser, V.; Hogl, B.; Poewe, W.; Vodicka, P.; Vavrova, J.; Sonka, K.; Nevsimalova, S.; Schormair, B.; Lichtner, P.; Silander, K.; Peltonen, L.; Gieger, C; Wichmann, H.E.; Zimprich, A.; Roeske, D.; Miiller-Myhsok, B.; Meitinger, T.; Winkelmann, J. Replication of restless legs syndrome loci in three European populations. J. Med. Genet. 2009, 46, 315-318. http://dx.doi.Org/10.l136/jmg.2008.062992
60. Hovatta, I.; Tennant, R.S.; Helton, R.; Marr, R.A.; Singer, O.; Redwine, J.M.; Ellison, J.A.; Schadt, E.E.; Verma, I.M.; Lockhart, D.J.; Barlow, C. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 2005, 438, 662-666.PMID: 16244648
61. Loos, M.; Van der Sluis, S.; Bochdanovits, Z.; van Zutphen, I.J.; Pattij, T.; Stiedl, O. Activity and impulsive action are controlled by different genetic and environmental factors. Genes Brain Behav. 2009, 8, 817-828. PMID: 19751396
62. Benton, C.S.; Miller, B.H.; Skwerer, S.; Suzuki, O.; Schultz, L.E.; Cameron, M.D.; Marron, J.S.; Pletcher, M.T.; Wiltshire, T. Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains. Psychopharmacology (Berl.) 2012, 221, 297-315. http://dx.doi.org/10.1007/s00213-011-2574-z
63. Ditzen, C; Jastorff, A.M.; Kepler, M.S.; Bunck, M.; Teplytska, L.; Erhardt, A.; Krömer, S.A.; Varadarajulu, J.; Targosz, B.S.; Sayan-Ayata, E.F.; Holsboer, F.; Landgraf, R.; Turck, C.W. Protein biomarkers in a mouse model of extremes in trait anxiety. Mol. Cell. Proteomic. 2006, 5, 1914-1920. http://dx.doi.org/10.1074/mcp.M600088-MCP200
64. Krömer, S.A.; Kepler, M.S.; Milfay, D.; Birg, I.N.; Bunck, M.; Czibere, L.; Panhuysen, M.; Piitz, B.; Deussing, J.M.; Holsboer, F.; Landgraf, R.; Turck, C.W. Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J. Neurosci. 2005, 25, 4375-4384. DOI: 10.1523/JNEUROSCI.0115-05.2005
65. Landgraf, R.; Kessler, M.S.; Bunck, M.; Murgatroyd, C; Spengler, D.; Zimbelmann, M.; Nussbaumer, M.; Czibere, L.; Turck, C.W.; Singewald, N.; Rujescu, D.; Frank, E. Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: focus on vasopressin and glyoxalase-I. Neurosci. Biobehav. Rev. 2007, 31, 89-102. http://dx.doi.Org/10.1016/j.neubiorev.2006.07.003
66. Thornalley, P J. Unease on the role of glyoxalase 1 in high-anxiety-related behaviour. Trends. Mol. Med. 2006, 12, 195-199. http://dx.doi.org/10.1016/j.molmed.2006.03.004
67. Williams, R., 4th; Lim, J.E.; Harr, B.; Wing, C; Walters, R.; Distler, M.G.; Teschke, M.; Wu, C; Wiltshire, T.; Su, A.I.; Sokoloff, G.; Tarantino, L.M.; Borevitz, J.O.; Palmer, A.A. A common and unstable copy number variant is associated with differences in GLO1 expression and anxiety-like behavior. PLoS One 2009,4, e4649. http://dx.doi.org/10.1371/journal.pone.0004649
68. Abordo, E.A.; Minhas, H.S.; Thornalley, P.J. Accumulation of a-oxoaldehydes during oxidative stress: a role in cytotoxicity. Biochem. Pharmacol. 1999, 58, 641-648. http://dx.doi.org/10.1016/j.marenvres.2004.03.114
69. Shinohara, M.; Thornalley, P.J.; Giardino, I.; Beisswenger, P.; Thorpe, S.R.; Onorato, J.; Brownlee, M. Overexpression of glyoxalase I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycaemia-induced increases in macromolecular endocytosis. J. Clin. Invest. 1998, 101, 1142-1147. http://dx.doi.org/10.1172/JCI119885
70. Thornalley, P.J. Antitumour activity of S-p-bromoben-zylglutathione cyclopentyl diester in vitro and in vivo: inhibition of glyoxalase I and induction of apoptosis. Biochem. Pharmacol. 1996, 51, 1365-1372. http://dx.doi.org/10.1016/0006-2952(96)00059-7
71. Cryan, J.F.; Holmes, A. The ascent of mouse: advances in modelling human depression and anxiety. Nat. Rev. Drug Discov. 2005, 4, 775-790. http://dx.doi.org/10.1038/nrd1825
72. Ranganathan, S.; Ciaccio, P.J.; Walsh, E.S.; Tew, K.D. Genomic sequence of human glyoxalase-I: analysis of promoter activity and its regulation. Gene 1999, 240, 149-155. http://dx.doi.org/10.1016/S0378-1119(99)00420-5
73. Knable, M.B.; Barci, B.M.; Webster, M.J.; Meador-Woodruff, J.; Torrey, E.F. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol. Psychiatry 2004, 9, 609-620. http://dx.doi.org/10.1038/sj.mp.4001471
74. Perlman, W.R.; Webster, M.J.; Kleinman, J.E.; Weickert, C.S. Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness. Biol. Psychiatry 2004, 56, 844-852. http://dx.doi.org/10.1016/j.biopsych.2004.09.006
75. Webster, M.J.; Knable, M.B.; O'Grady, J.; Orthmann, J.; Weickert, C.S. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol. Psychiatry 2002, 7, 985-994. http://dx.doi.org/10.1038/sj.mp.4001139
76. Eser, D.; Uhr, M.; Leicht, G.; Asmus, M.; Länger, A.; Schüle, C.; Baghai, T.C.; Mulert, C.; Rupprecht, R. Glyoxalase-I mRNA expression and CCK-4 induced panic attacks. J. Psychiatr. Res. 2011, 45, 60-63. http://dx.doi.org/10.1016/j.jpsychires.2010.05.008
77. Bradwejn, J.; Koszycki, D. Cholecystokinin and panic disorder: past and future clinical research strategies. Scand. J. Clin. Lab. Invest. Suppl. 2001, 234, 19-27. http://dx.doi.org/10.1080/clb.61.234.19.27
78. Eser, D.; Schule, C.; Baghai, T.; Floesser, A.; Krebs-Brown, A.; Enunwa, M.; de la Motte, S.; Engel, R.; Kucher, K.; Rupprecht, R. Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study. Psychopharmacology (Berl.) 2007, 192, 479-487. http://dx.doi.org/10.1007/s00213-007-0738-7
79. Rupprecht, R.; Rammes, G.; Eser, D.; Baghai, T.C.; Schüle, C.; Nothdurfter, C.; Troxler, T.; Gentsch, C.; Kalkman, H.O.; Chaperon, F.; Uzunov, V.; McAllister, K.H.; Bertaina-Anglade, V.; La Rochelle, C.D.; Tuerck, D.; Floesser, A.; Kiese, B.; Schumacher, M.; Landgraf, R.; Holsboer, F.; Kucher, K. Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science, 2009, 325, 1072. ISSN: 00368075
80. Vollert, C.; Zagaar, M.; Hovatta, I.; Taneja, M.; Vu, A.; Dao, A.; Levine, A.; Alkadhi, K.; Salim, S. Exercise prevents sleep deprivation-associated anxiety-like behavior in rats: potential role of oxidative stress mechanisms. Behav. Brain Res. 2011, 224, 233-240. doi: 10.1016/j.bbr.2011.05.010
81. Hambsch, B.; Chen, B.G.; Brenndörfer, J.; Meyer, M.; Avrabos, C.; Maccarrone, G.; Liu, R.H.; Eder, M.; Turck, C.W.; Landgraf, R. Methylglyoxal-mediated anxiolysis involves increased protein modification and elevated expression of glyoxalase 1 in the brain. J. Neurochem. 2010, 113, 1240-1251. DOI: 10.1111/j.1471-4159. 2010.06693.x
82. Distler, M.G.; Plant, L.D.; Sokoloff, G.; Hawk, A.J.; Aneas, I.; Wuenschell, G.E.; Termini, J.; Meredith, S.C.; Nobrega, M.A.; Palmer, A.A. Glyoxalase 1 increases anxiety by reducing GABAA receptor agonist methylglyoxal. J. Clin. Invest. 2012, 122, 2306-2315. http://dx.doi.org/10.1172/JCI61319
83. Kalapos, M.P. Methylglyoxal in living organisms: chemistry, biochemistry, toxicology and biological implications. Toxicol. Lett. 1999, 110, 145-175. http://dx.doi.org/10.1016/S0378-4274(99)00160-5
84. Kalapos, M.P.; Littauer, A.; de Groot, H. Has reactive oxygen a role in methylglyoxal toxicity? A study on cultured rat hepatocytes. Arch. Toxicol. 1993, 67, 369-372. http://dx.doi.org/10.1007/BF01973710
85. Okado, A.; Kawasaki, Y.; Hasuike, Y.; Takahashi, M.; Teshima, T.; Fujii, J.; Taniguchi, N. Induction of apoptotic cell death by methylglyoxal and 3-deoxyglucosone in macrophage-derived cell lines. Biochem. Biophys. Res. Commun. 1996, 225, 219-224. http://dx.doi.org/10.1006/bbrc.1996.1157
86. Chang, T.; Wang, R.; Wu, L. Methylglyoxal-induced nitric oxide and peroxynitrite production in vascular smooth muscle cells. Free Radic. Biol. Med. 2005, 38, 286-293. http://dx.doi.org/10.1016/j.freeradbiomed.2004.10.034
87. Kikuchi, S.; Shinpo, K.; Moriwaka, F.; Makita, Z.; Miyata, T.; Tashiro, K. Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical neurons: synergism between glycation and oxidative stress, possibly involved in neurodegenerative diseases. J. Neurosci. Res. 1999, 57, 280-289.PMID: 10398306
88. Breborowicz, A.; Witowski, J.; Polubinska, A.; Pyda, M.; Oreopoulos, D. L-2-oxothiazolidine-4-carboxylic acid reduces in vitro cytotoxicity of glucose degradation products. Nephrol. Dial. Transplant. 2004, 19, 3005-3011. http://dx.doi.org/10.1093/ndt/gfh539
89. Wittmann, I.; Mazák, I.; Pótó, L.; Wagner, Z.; Wagner, L.; Vas, T.; Kovács, T.; Belágyi, J.; Nagy, J. Role of iron in the interaction or red blood cells with methylglyoxal: modification of L-arginine by methylglyoxal is catalyzed by iron redox cycling. Chem. Biol. Interact. 2001, 138, 171-187. http://dx.doi.org/10.1016/S0009-2797(01)00269-1
90. Du, J.; Suzuki, H.; Nagase, F.; Akhand, A.A.; Ma, X.Y.; Yokoyama, T.; Miyata, T.; Nakashima, I. Superoxide-mediated early oxidation and activation of ASK1 are important for initiating methylglyoxal-induced apoptosis process. Free Radic. Biol. Med. 2001, 31, 469-478. http://dx.doi.org/10.1016/S0891-5849(01)00611-6
91. Che, W.; Asahi, M.; Takahashi, M.; Kaneto, H.; Okado, A.; Higashiyama, S.; Taniguchi, N. Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells: the involvement of reactive oxygen species formation and a possible implication for atherogenesis in diabetes. J. Biol. Chem. 1997, 272, 18453-18459. http://dx.doi.org/10.1074/jbc.272.29.18453
92. Okado, A.; Kawasaki, Y.; Hasuike, Y.; Takahashi, M.; Teshima, T.; Fujii, J.; Taniguchi, N. Induction of apoptotic cell death by methylglyoxal and 3-deoxyglucosone in macrophage-derived cell lines. Biochem. Biophys. Res. Commun. 1996, 225, 219-224. http://dx.doi.org/10.1006/bbrc.1996.1157
93. Du, J.; Suzuki, H.; Nagase, F.; Akhand, A.A.; Ma, X.Y.; Yokoyama, T.; Miyata, T.; Nakashima, I. Superoxide-mediated early oxidation and activation of ASK1 are important for initiating methylglyoxal-induced apoptosis process. Free Radic. Biol. Med. 2001, 31, 469-478. http://dx.doi.org/10.1016/S0891-5849(01)00611-6
94. Kroemer, G.; Reed, J.C. Mitochondrial control of cell death. Nat. Med. 2000, 6, 513-519.PMID: 10802706
95. Leoncini, G.; Maresca, M.; Buzzi, E. Inhibition of the glycolytic pathway by methylglyoxal in human platelets. Cell Biochem. Funct. 1989, 7, 65-70. http://dx.doi.org/10.1002/cbf.290070111
96. Shamsi, F.A.; Lin, K.; Sady, C.; Nagaraj, R.H. Methylglyoxal-derived modifications in lens aging and cataract formation. Invest. Ophthalmol. Vis. Sci. 1998, 39, 2355-2364. PubMed ID: 9804144
97. Wu, L.; Juurlink, B.H.J. Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension 2002, 39, 809-814. http://dx.doi.org/10.1161/hy0302.105207
98. Kalapos, M.P.; Garzó, T.; Antoni, F.; Mandl, J. Effect of methylglyoxal on glucose formation, drug oxidation and glutathione content in isolated murine hepatocytes. Biochim. Biophys. Acta 1991, 1092, 284-290. http://dx.doi.org/10.1016/S0167-4889(97)90002-1
99. Kalapos, M.P.; Garzó, T.; Antoni, F.; Mandl, J. Accumulation of S-D-lactoylglutathione and transient decrease of glutathione level caused by methylglyoxal load in isolated hepatocytes. Biochim. Biophys. Acta 1992, 1135, 159-164. http://dx.doi.org/10.1016/0167-4889(92)90132-U
100. Baskaran, S.; Balasubramanian, K.A. Effect of methylglyoxal on protein thiol and amino groups in isolated rat enterocytes and colonocytes and activity of various brush border enzymes. Indian J. Biochem. Biophys. 1989, 27, 13-17. PubMed ID: 2341160
101. Braun, L.; Garzó, T.; Riba, P.; Mandl, J.; Kalapos, M.P. Methylglyoxal and cell viability. Int. J. Biochem. 2004, 26, 987-990. http://dx.doi.org/10.1016/0020-711X(94)90069-8
102. Kalapos, M.P.; Schaff, Z.; Garzó, T.; Antoni, A.; Mandl, J. Accumulation of phenols in isolated murine hepatocytes after pretreatment with methylglyoxal. Toxicol. Lett. 1991, 58, 181-191. http://dx.doi.org/10.1016/0378-4274(91)90172-3
103. Kalapos, M.P. Influence of acetone on the hepatotoxicity of methylglyoxal. Med. Sci. Res. 1999, 27, 617-620. ISSN: 02698951
104. Choudhary, D.; Chandra, D.; Kale, R.K. Influence of methylglyoxal on antioxidant enzymes and oxidative damage. Toxicol. Lett. 1997, 93, 141-152. http://dx.doi.org/10.1016/S0378-4274(97)00087-8
105. Amicarelli, F.; Bonfigli, A.; Colafarina, S.; Bucchiarelli, T.; Principato G.; Ragnelli, A.M.; Di Ilio, C; Miranda, M. Effect of methylglyoxal on Bufo bufo embryo development: morphological and biochemical aspects. Chem. Biol. Interact. 1998, 114, 177-189.PMID: 9839630
106. Ankrah, N.A.; Appiah-Opong, R. Toxicity of low levels of methylglyoxal: depletion of blood glutathione and adverse effect on glucose tolerance in mice. Toxicol. Lett. 1999, 109, 61-67. http://dx.doi.org/10.1016/S0378-4274(99)00114-9
107. Kalapos, M.P. The tandem of free radicals and methylglyoxal. Chem. Biol. Interact. 2008, 171, 251-271. http://dx.doi.org/10.1016/j.cbi.2007.11.009
108. Kalapos, M.P. Methylglyoxal toxicity in mammals. Toxicol. Lett. 1994, 75, 3-24. http://dx.doi.org/10.1016/0378-4274(94)90184-8
109. Wu, L.; Juurlink, B.HJ. Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension 2002, 39, 809-814. http://dx.doi.org/10.1161/hy0302.105207
110. Kalapos, M.P. Influence of acetone on the hepatotoxicity of methylglyoxal. Med. Sci. Res. 1999, 27, 617-620 ISSN: 02698951
111. Amicarelli, F.; Colafarina, S.; Cattani, F.; Cimini, A.; Di Ilio, C; Ceru, M.P.; Miranda, M. Scavenging system efficiency is crucial for cell resistance to ROS-mediated methylglyoxal injury. Free Radic. Biol. Med. 2003, 35, 856-871. http://dx.doi.org/10.1016/S0891-5849(03)00438-6
112. Vander, J.D.L.; Hunsaker, L.A.; Vander, J.T.J.; Gomez, M.S.; Gonzales, D.M.; Deck, L.M.; Royer, R.E. Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes. Biochem. Pharmacol. 1997, 53, 1133-1140. http://dx.doi.org/10.1016/S0006-2952(97)00090-7
113. Poynter, M.E.; Daynes, R.A. Peroxisome proliferator-activated receptor activation modulates cellular redox status, represses nuclear factor-KB signalling, and reduces inflammatory cytokine production in aging. J. Biol. Chem. 1998, 273, 32833-32841. http://dx.doi.org/10.1074/jbc.273.49.32833
114. Inoue, I.; Noji, S.; Awata, T.; Takahashi, K.; Nakajima, T.; Sonoda, M.; Komoda, T.; Katayama, S. Bezafibrate has an antioxidant effect: peroxisome proliferator-activated receptor a is associated with Cu2+, Zn2+-superoxide dismutase in the liver. Life Sci. 1998, 63, 135-144. DOI: 10.1016/S0024-3205(98)00249-5
115. Dougherty, C.J.; Kubasiak, L.A.; Prentice, H.; Andreka, P.; Bishopric, N.H.; Webster, K.A. Activation of c-Jun N-terminal kinase promotes survival of cardiac myocytes after oxidative stress. Biochem. J. 2002, 362, 561-571. PMCID: PMC1222419
116. Del, R.M.J.; Velez-Pardo, C. Monoamine neurotoxins-induced apoptosis in lymphocytes by a common oxidative stress mechanism: involvement of hydrogen peroxide (H2O2), caspase-3, and nuclear factor kappa-B (NF-kB), p53, c-Jun, transcription factors. Biochem. Pharmacol. 2002, 63, 677-688. http://dx.doi.org/10.1016/S0006-2952(01)00907-8
117. Li, N.; Karin, M. Is NF-kB the sensor of oxidative stress? FASEB J. 1999,13, 1137-1143.PMID: 10385605
118. Amicarelli, F.; Colafarina, S.; Cattani, F.; Cimini, A.; Di Ilio, C; Ceru, M.P.; Miranda, M. Scavenging system efficiency is crucial for cell resistance to ROS-mediated methylglyoxal injury. Free Radical Biol. Med., 2003, 35, 856-871. http://dx.doi.org/10.1016/S0891-5849(03)00438-6
119. Wu, L.; Juurlink, B.H. Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension 2002,39, 809-814. http://dx.doi.org/10.1161/hy0302.105207
120. Corbett, R.; Dunn, R.W. Effects of HA-966 on conflict, social interaction, and plus maze behaviors. Drug Dev. Res. 1991, 24, 201-205. http://dx.doi.org/10.1002/ddr.430240302
121. Corbett, R.; Dunn, R.W. Effects of 5,7 dichlorokynurenic acid on conflict, social interaction and plus maze behaviors. Neuro-pharmacology 1993, 32, 461-466. http://dx.doi.org/10.1016/0028-3908(93)90170-8
122. Dunn, R.W.; Corbett, R.; Fielding, S. Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze. Eur. J. Pharmacol. 1989, 169, 1-10. http://dx.doi.org/10.1016/0014-2999(89)90811-X
123. Jessa, M.; Nazar, M.; Bidzinski, A.; Plaznik, A. The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in two models of anxiety. Eur. Neuropsychopharmacol. 1996, 6, 55-61. http://dx.doi.org/10.1016/0924-977X(95)00068-Z
124. Plaznik, A.; Palejko, W.; Nazar, M.; Jessa, M. Effects of antagonists at the NMDA receptor complex in two models of anxiety. Eur. Neuropsychopharmacol. 1994, 4, 503-512. http://dx.doi.org/10.1016/0924-977X(94)90299-2
125. Soderpalm, A.K.; Blomqvist, O.; Engel, J.A.; Soderpalm, B. Characterization of the anticonflict effect of MK-801, a non-competitive NMDA antagonist. Pharmacol. Toxicol. 1995, 76, 122-127. http://dx.doi.org/10.1111/j.1600-0773.1995.tb00116.x
126. Xie, Z.; Commissaris, R.L. Anxiolytic-like effects of the noncompetitive NMDA antagonist MK 801. Pharmacol. Biochem. Behav. 1992, 43, 471-477. http://dx.doi.org/10.1016/0091-3057(92)90178-I
127. Bertoglio, L.J.; Carobrez, A.P. Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats. Psychopharmacology (Berl.) 2003,170, 335-342. http://dx.doi.org/10.1007/s00213-003-1558-z
128. Porter, J.H.; Wiley, J.L.; Balster, R.L. Effects of phencyclidine-like drugs on punished behavior in rats. J. Pharmacol. Exp. Ther. 1989, 248, 997-1002. PubMed ID: 2539469
129. Malizia, A.L.; Cunningham, V.J.; Bell, C.J.; Liddle, P.F.; Jones, T.; Nutt, D.J. Decreased brain GABAA-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch. Gen. Psychiatry 1998, JJ, 715-720. PMID: 9707382
130. Goddard, A.W.; Mason, G.F.; Almai, A.; Rothman, D.L.; Behar, K.L.; Petroff, O.A.; Charney, D.S.; Krystal, J.H. Reductions in occipital cortex GABA levels in panic disorder detected with 1H-magnetic resonance spectroscopy. Arch. Gen. Psychiatry 2001, 58, 556-561.PMID: 11386984
131. Rosahl, T.W. Validation of GABAA receptor subtypes as potential drug targets by using genetically modified mice. Curr. Drug Targets CNS Neurol. Disord. 2003, 2, 207-212. http://dx.doi.org/10.2174/1568007033482823
132. Mombereau, C; Kaupmann, K.; Gassmann, M.; Bettler, B.; van der Putten, H.; Cryan, J.F. Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits. Neuroreport 2005, 16, 307-310. http://dx.doi.org/10.1097/00001756-200502280-00021
133. Mombereau, C; Kaupmann, K.; Froestl, W.; Sansig, G.; van der Putten, H.; Cryan, J.F. Genetic and pharmacological evidence of a role for GABAB receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology 2004, 29, 1050-1062. http://dx.doi.org/10.1038/sj.npp.1300413
134. Kash, S.F.; Tecott, L.H.; Hodge, C; Baekkeskov, S. Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 1698-1703. http://dx.doi.org/10.1073/pnas.96.4.1698
135. Chandra, D.; Korpi, E.R.; Miralles, C.P.; De Blas, A.L.; Homanics, G.E. GABAa receptor y2 subunit knockdown mice have enhanced anxiety-like behavior but unaltered hypnotic response to benzodiazepines. BMC Neurosci. 2005, 6, 30. DOI: 10.1186/1471-2202-6-30
136. Distler, M.G.; Plant, L.D.; Sokoloff, G.; Hawk, A.J.; Aneas, I.; Wuenschell, G.E.; Termini, J.; Meredith, S.C.; Nobrega, M.A.; Palmer, A.A. Glyoxalase 1 increases anxiety by reducing GABAA receptor agonist methylglyoxal. J. Clin. Invest. 2012, 122, 2306-2315. http://dx.doi.org/10.1172/JCI61319
137. Ansorge, M.S.; Zhou, M.; Lira, A.; Hen, R.; Gingrich, J.A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004, 306, 879-881. http://dx.doi.org/10.1126/science.1101678
138. Gross, C; Zhuang, X.; Stark, K.; Ramboz, S.; Oosting, R.; Kirby, L.; Santarelli, L.; Beck, S.; Hen, R. SerotoniniA receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002,416, 396-400. http://dx.doi.org/10.1038/416396a
139. Clément, Y.; Calatayud, F.; Belzung, C. Genetic basis of anxietylike behaviour: a critical review. Brain Res. Bull. 2002, 57, 57-71. http://dx.doi.Org/l0.1016/S0361-9230(01)00637-2
140. Gingrich, J.A. Oxidative stress is the new stress. Nat. Med. 2005, 11, 1281-1282. http://dx.doi.org/10.1038/nml205-1281
141. Kim, K.M.; Kim, Y.S.; Jung, D.H.; Lee, J.; Kim J.S. Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose. Exp. Cell. Res. 2012, 318, 152-159. http://dx.doi.org/10.1016/j.yexcr.2011.10.013
142. Nemet, I.; Varga- Defterdarovic, L.; Turk, Z. Methylglyoxal in food and living organisms. Mol. Nutr. Food Res. 2006, 50, 11. http://dx.doi.org/10.1002/mnfr.200600065
143. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414, 813-820. http://dx.doi.org/10.1038/414813a
144. Ahmed, N.; Thornalley, P J. Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes Obes. Metab. 2007, 9, 233-245. http://dx.doi.Org/10.llll/j.1463-1326.2006.00595.x
145. Distler, M.G.; Gorfmkle, N.; Papale, L.A.; Wuenschell, G.E.; Termini, J.; Escayg, A.; Winawer, M.R.; Palmer, A.A. Glyoxalase 1 and its substrate methylglyoxal are novel regulators of seizure susceptibility. Epilepsia 2013, 54, 649-657. http://dx.doi.org/10.Ill1/epi.12121
146. Salim, S. Oxidative stress in anxiety: implications for pharma-cotherapy. Am. J. Integr. Med. 2011, 1, 11-21. http://dx.doi.org/10.1093/med/9780199557837.003.0005
147. Bouayed, J. Relationship between oxidative stress and anxiety: emerging role of antioxidants within therapeutic or preventive approaches. In: Kalinin, V.V. (Ed.), ISBN: 978-953-307-592-1, InTech, DOI: 10.5772/19214. ISBN: 978-953-307-592-1, InTech, DOI: 10.5772/19214.
148. Augustyniak, A.; Bartosz, G.; Cipak, A.; Duburs, G.; Horáková, L.U.; Luczaj, W.; Majekova, M.; Odysseos, A.D.; Rackova, L.; Skrzydlewska, E.; Stefek, M.; Strosová, M.; Tirzitis, G.; Venskutonis, P.R.; Viskupicova, J.; Vraka, P.S.; Zarkovic, N. Natural and synthetic antioxidants: an updated overview. Free Radio. Res. 2010, 44, 1216-1262. http://dx.doi.org/10.3109/10715762.2010.508495
149. Bouayed, J.; Bohn, T. Exogenous antioxidants-double-edged swords in cellular redox state: health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid. Med. Cell. Longev. 2010, 3, 228-237. http://dx.doi.org/10.4161/oxim.3.4.12858
150. Atmaca, M.; Tezcan, E.; Kuloglu, M.; Ustundag, B.; Tunckol, H. Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment. Eur. Arch. Psychiatry Clin. Neurosci. 2004, 245, 231-235. DOI: 10.1007/s00406-004-0484-3
151. Réus, G.Z.; Stringari, R.B.; de Souza, B.; Petronilho, F.; Dal-Pizzol, F.; Hallak, J.E.; Zuardi, A.W.; Crippa, J.A.; Quevedo, J. Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus. Oxid. Med. Cell. Longev. 2010, 3, 325-331. http://dx.doi.Org/10.4161/oxim.3.5.13109
152. Viggiano, A.; Viggiano, A.; Monda, M.; Turco, I.; Incarnate, L.; Vinno, V.; Viggiano, E.; Baccari, M.E.; De Luca, B. Annurca apple-rich diet restores long-term potentiation and induces behavioral modifications in aged rats. Exp. Neurol. 2006,199, 354-361. http://dx.doi.Org/l0.1016/j.expneurol.2006.01.001
153. Chepulis, L.M.; Starkey, N.J.; Waas, J.R.; Molan, P.C. The effects of long-term honey, sucrose or sugar-free diets on memory and anxiety in rats. Physiol. Behav. 2009, 97, 359-368. http://dx.doi.Org/10.1016/j.physbeh.2009.03.001
154. Singh, R.P.; Sharad, S.; Kapur, S. Free radicals and oxidative stress in neurodegenerative diseases: relevance of dietary antioxidants. J. Indian Acad. Clin. Med. 2004, J, 218-225.
155. Hely, M.A.; Fung, V.S.; Morris, J.G. Treatment of Parkinson's disease. Clin. Neurosci. 2007, 7, 484-494.PMID: 11029227
156. Behl, C; Davies, J.; Cole, G.M.; Schubert, D. Vitamin E protects nerve cells from amyloid (3 protein toxicity. Biochem. Biophys. Res. Commun. 1992,186, 944-950.PMID: 1497677
157. Virmani, A.; Gaetani, F.; Imam, S.; Binienda, Z.; Ali, S. Possible mechanism for the neuroprotective effects of L-carnitine on methamphetamine-evoked neurotoxicity. Ann. N. Y. Acad. Sci. 2006,995, 197-207.PMID: 12853314
158. Wakamatsu, K.; Fujikawa, K.; Zucca, F.A.; Zecca, L.; Ito, S. The structure of neuromelanin as studied by chemical degradative methods. J. Neurochem. 2003, 86, 1015-1023.PMID: 12887698
159. Nogueira, C.W.; Rocha, J.B. Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds. Arch. Toxicol. 2011, 85, 1313-1359. http://dx.doi.org/10.1007/s00204-011-0720-3
160. Nogueira, C.W.; Zeni, G.; Rocha, J.B. Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem. Rev. 2004,704, 6255-6285. http://dx.doi.org/10.1021/cr0406559
161. Rocha, J.B.T.; Saraiva, R.A.; Garcia, S.C.; Gravina, F.S.; Nogueira, C.W. Aminolevulinatedehydratase (5-ALA-D) as marker protein of intoxication with metals and other pro-oxidant situations. Toxicol. Res. 2012,1, 85-102.
162. Parnham, M.J., Kindt, S. A novel biologically active seleno-organic compound: III. Effects of PZ-51 (Ebselen) on glutathione peroxidase and secretory activities of mouse macrophages. Biochem. Pharmacol. 1984, 33, 3247-3250. http://dx.doi.org/10.1016/0006-2952(84)90085-6
163. Wendel, A.; Fausel, M.; Safayhi, H.; Tiegs, G.; Otter, R. A novel biologically active seleno-organic compound: II. Activity of PZ 51 in relation to glutathione peroxidase. Biochem. Pharmacol. 1984, 33, 3241-3245. http://dx.doi.org/10.1016/0006-2952(84)90084-4
164. Miiller, A.; Cadenas, E.; Graf, P.; Sies, H. A novel biologically active seleno-organic compound: I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen). Biochem. Pharmacol. 1984, 33, 3235-3239. http://dx.doi.org/10.1016/0006-2952(84)90083-2
165. Engman, L.; Stern, D.; Cotgreave, LA.; Andersson, CM. Thiol peroxidase activity of diaryl ditellurides as determined by a proton NMR method. J. Am. Chem. Soc. 1992, 114, 9737-9743. http://dx.doi.org/10.1021/ja00051a002
166. Iwaoka, M.; Tomoda, S. A model study on the effect of an amino group on the antioxidant activity of glutathione peroxidase. J. Am. Chem Soc. 1994, 116, 2557-2561. http://dx.doi.org/10.1021/ja00085a040
167. Li, J.; Chen, J.J.; Zhang, F.; Zhang, C. Ebselen protection against hydrogen peroxide-induced cytotoxicity and DNA damage in HL-60 cells. Ada. Pharmacol. Sin. 2000, 21, 455-459.PMID: 11324446
168. Ostrovidov, S.; Franck, P.; Joseph, D.; Martarello, L.; Kirsch, G.; Belleville, F.; Nabet, P.; Dousset, B. Screening of new antioxidant molecules using flow cytometry. J. Med. Chem. 43, 1762-1769. http://dx.doi.org/10.1021/jm991019j
169. Hassan, W.; Ibrahim, M.; Deobald, A.M.; Braga, A.L.; Nogueira, C.W.; Rocha, J.B.T. pH-Dependent Fe(II) pathophysiology and protective effect of an organoselenium compound. FEBS Lett. 2009, 583, 1011-1016. http://dx.doi.Org/10.1016/j.febslet.2009.02.020
170. Hassan, W.; Ibrahim, M.; Nogueira, C.W.; Braga, A.L.; Mohammadzai, I.U.; Taube, P.S.; Rocha, J.B.T. Enhancement of iron-catalyzed lipid peroxidation by acidosis in brain homogenate: comparative effect of diphenyl diselenide and ebselen. Brain Res. 2009,1258, 71-71. http://dx.doi.Org/10.1016/j.brainres.2008.12.046
171. Sies, H.; Klotz, L.O.; Sharov, V.S.; Assmann, A.; Briviba, K. Protection against peroxynitrite by selenoproteins. Z. Naturforsch. C 1998, 53, 228-232.PMID: 9618937
172. Zhao, R.; Holmgren, A. A novel antioxidant mechanism of ebselen involving ebselen diselenide, a substrate of mammalian thioredoxin and thioredoxin reductase. J. Biol. Chem. 2002, 277, 39456-39462. http://dx.doi.org/10.1074/jbc.M206452200
173. Zhao, R.; Masayasu, H.; Holmgren, A. Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 8579-8584. http://dx.doi.org/10.1073/pnas.122061399
174. Sausen de Freitas, A.; de Souza Prestes, A.; Wagner, C; Haigert Sudati, J.; Alves, D.; Oliveira Porciiincula, L.; Kade, I.J.; Rocha, J.B.T. Reduction of diphenyl diselenide and analogs by mammalian thioredoxin reductase is independent of their gluthathione peroxidase-like activity: a possible novel pathway for their antioxidant activity. Molecules 2010, 15, 7699-7714. http://dx.doi.org/10.3390/moleculesl5117700
175. Arteel, G.E.; Briviba, K.; Sies, H. Function of thioredoxin reductase as a peroxynitrite reductase using selenocystine or ebselen. Chem. Res. Toxicol. 1999, 12, 264-269. http://dx.doi.org/10.1021/tx980223r
176. Mugesh, G.; Klotz, L.O.; du Mont, W.W.; Becker, K.; Sies, H. Selenenyl iodide: a new substrate for mammalian thioredoxin reductase. Org. Biomol. Chem. 2003,1, 2848-2852.
177. Kuhl, P.; Borbe, H.O.; Fischer, FL; Römer, A.; Safayhi, H. Ebselen reduces the formation of LTB4 in human and porcine leukocytes by isomerisation to its 5S, 12R-6-trans-isomer. Prostaglandins 1986, 31, 1029-1048. http://dx.doi.org/10.1016/0090-6980(86)90207-8
178. Leurs, R.; Timmerman, FL; Bast, A. Inhibition of superoxide anion radical production by ebselen (PZ51) and its sulfur analogue (PZ25) in guinea pig alveolar macrophages. Biochem. Int. 1989,18, 295-299.PMID: 2548505
179. Jozsef, L.; Filep, J.G. Selenium-containing compounds attenuate peroxynitrite-mediated NF-kB and AP-1 activation and interleukin-8 gene and protein expression in human leukocytes. Free. Radio. Biol. Med. 2003, 35, 1018-1027. http://dx.doi.org/10.1016/S0891-5849(03)00439-8
180. Zhang, M.; Nomura, A.; Uchida, Y.; Iijima, FL; Sakamoto, T.; Iishii, Y.; Morishima, Y.; Mochizuki, M.; Masuyama, K.; Hirano, K.; Sekizawa, K. Ebselen suppresses late airway responses and airway inflammation in guinea pigs. Free. Radio. Biol. Med. 2002, 32, 454-464. http://dx.doi.org/10.1016/S0891-5849(01)00825-5
181. Tchoumkeu-Nzouessa, G.C.; Rebel, G. Differential effect of ebselen on compound 48/80- and anti-IgE-induced histamine release from rat peritoneal mast cells. Biochem. Pharmacol. 1998, 56, 1525-1528. http://dx.doi.org/10.1016/S0006-2952(98)00252-4
182. Nogueira, C.W.; Quinhones, E.B.; Jung, E.A.C.; Zeni, G.; Rocha, J.B.T. Anti-inflammatory and antinociceptive activity of diphenyl diselenide. Inflamm. Res. 2003, 52, 56-63. http://dx.doi.org/10.1007/sOOO110300001
183. Savegnago, L.; Jesse, C.R.; Santos, A.R.S.; Rocha, J.B.T., Nogueira, C.W. Mechanisms involved in the antinociceptive effect caused by diphenyl diselenide in the formalin test. J. Pharm. Pharmacol. 2008, 60, 1679-1686. http://dx.doi.org/10.1211/jpp/60.12.0015
184. Zasso, F.; Goncales, C.E.P.; Jung, E.A.C.; Araldi, D.; Zeni, G.; Rocha, J.B.T.; Nogueira, C.W. On the mechanisms involved in antinociception induced by diphenyl diselenide. Environ. Toxicol. Pharmacol. 2005, 19, 283-289. http://dx.doi.Org/10.1016/j.etap.2004.08.003
185. Meotti, F.C.; Coelho, I.S.; Franco, J.L.; Dafre, A.L.; Rocha, J.B.T.; Santos, A.R.S. Redox modulation at the peripheral site alters nociceptive transmission in vivo. Clin. Exp. Pharmacol. Physiol. 2009,36, 272-277. http://dx.doi.0rg/lO.l111/J.1440-1681.2008.05056.X
186. Savegnago, L.; Pinto, L.G.; Jesse, C.R.; Rocha, J.B.T.; Nogueira, C.W.; Zeni, G. Spinal mechanisms of antinociceptive action caused by diphenyl diselenide. Brain. Res. 2007, 1162, 32-37. http://dx.doi.org/10.1016/j.brainres.2007.04.086
187. Wendel, A., Tiegs, G. A novel biologically active seleno-organic compound: VI. Protection by ebselen (PZ 51) against galactosamine/ endotoxin-induced hepatitis in mice. Biochem. Pharmacol. 1986, 35, 2115-2118. http://dx.doi.org/10.1016/0006-2952(86)90578-2
188. Li, Q.J.; Bessems, J.G.; Commandeur, J.N.; Adams, B.; Vermeulen, N.P. Mechanism of protection of ebselen against paracetamol-induced toxicity in rat hepatocytes. Biochem. Pharmacol. 1994, 48, 1631-1640. http://dx.d0i.0rg/l0.1016/0006-2952(94)90208-9
189. Borges, L.P.; Borges, V.C.; Moro, A.V.; Nogueira, C.W.; Rocha, J.B.T.; Zeni, G. Protective effect of diphenyl diselenide on acute liver damage induced by 2-nitropropane in rats. Toxicology 2005, 210, 1-8. http://dx.doi.Org/10.1016/j.tox.2005.01.002
190. Wilhelm, E.A.; Jesse, C.R., Leite, M.R., Nogueira, C.W. Studies on preventive effects of diphenyl diselenide on acetaminophen-induced hepatotoxicity in rats. Pathophysiology 2009, 16, 31-37. http://dx.d0i.0rg/l0.1016/j.pathophys.2008.12.002
191. Ibrahim, M.; Prigol, M.; Hassan, W.; Nogueira, C.W.; Rocha, J.B.T. Protective effect of binaphthyl diselenide, a synthetic organoselenium compound, on 2-nitropropane-induced hepatotoxicity in rats. Cell. Biochem. Fund. 2010, 28, 258-265. http://dx.doi.org/10.1002/cbf.1645
192. Ohta, Y.; Kobayashi, T.; Inui, K.; Yoshino, J.; Nakazawa, S. Protective effect of ebselen, a seleno-organic compound, against the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. Jpn. J. Pharmacol. 2002, 90, 295-303. http://dx.doi.org/10.1254/jjp.90.295
193. Ineu, R.P.; Pereira, M.E.; Aschner, M.; Nogueira, C.W.; Zeni, G.; Rocha, J.B.T. Diphenyl diselenide reverses gastric lesions in rats: involvement of oxidative stress. Food. Chem. Toxicol. 2008, 46, 3023-3029. http://dx.doi.org/10.1016/j.fct.2008.06.007
194. Tabuchi, Y.; Ogasawara, T.; Furuhama, K. Mechanism of the inhibition of hog gastric (H+, K+)-ATPase by the seleno-organic compound ebselen. Arzneimittel-Forschung 1994, 44, 51-54. PubMed ID: 8135879
195. Beil, W.; Staar, U.; Sewing, K.F. Interaction of the anti-inflammatory seleno-organic compound ebselen with acid secretion in isolated parietal cells and gastric H+/K+-ATPase. Biochem. Pharmacol. 1990, 40, 1997-2003. PubMed ID: 2173597
196. Tabuchi, Y.; Sugiyama, N.; Horiuchi, T.; Furusawa, M.; Furuhama, K. Ebselen, a seleno-organic compound, protects against ethanol-induced murine gastric mucosal injury in both in vivo and in vitro systems. Eur. J. Pharmacol. 1995, 272, 195-201. http://dx.doi.org/10.1016/0014-2999(95)90819-U
197. Ibrahim, M.; Luchese, C.; Pinton, S.; Roman, S.S.; Hassan, W.; Nogueira, C.W.; Rocha, J.B.T. Involvement of catalase in the protective effect of binaphthyl diselenide against renal damage induced by glycerol. Exp. Toxicol. Pathol. 2011, 63, 331-335. http://dx.doi.org/10.1016/j.etp.2010.02.007
198. Brandão, R.; Acker, C.I.; Leite, M.R.; Barbosa, N.B.V.; Nogueira, C.W. Diphenyl diselenide protects against glycerol induced renal damage in rats. J. Appl. Toxicol. 2009, 29, 612-618. http://dx.doi.org/10.1002/jat.1449
199. Dhanarajan, R.; Abraham, P.; Isaac, B. Protective effect of ebselen, a selenoorganic drug, against gentamicin-induced renal damage in rats. Basic Clin. Pharmacol. Toxicol. 2006, 99, 267-272. http://dx.doi.org/10.1111/j.1742-7843.2006.pto_474.x
200. Yoshida, M.; Iizuka, K.; Terada, A.; Hara, M.; Nishijima, H.; Shimada, A.; Nakada, K.; Satoh, Y.; Akama, Y. Prevention of nephrotoxicity of cisplatin by repeated oral administration of ebselen in rats. Tohoku J. Exp. Med. 2000, 191, 209-220. http://dx.doi.org/10.1620/tjem.191.209
201. Noiri, E.; Nakao, A.; Uchida, K.; Tsukahara, H.; Ohno, M.; Fujita, T.; Brodsky, S.; Goligorsky, M.S. Oxidative and nitrosative stress in acute renal ischemia. Am. J. Physiol. Renal Physiol. 2001, 281, F948-F957. PubMed ID: 11592952
202. Saad, S.Y.; Najjar, T.A.; Arafah, M.M. Cardioprotective effects of subcutaneous ebselen against daunorubicin-induced cardio-myopathy in rats. Basic Clin. Pharmacol. Toxicol. 2006, 99, 412-417. http://dx.doi.org/10.1111/j.1742-7843.2006.pto_523.x
203. de Bem, A.F.; Farina, M.; Portella, R.L.; Nogueira, C.W.; Dinis, T.C.; Laranjinha, J.A.; Almeida, L.M.; Rocha, J.B.T. Diphenyl diselenide, a simple glutathione peroxidase mimetic, inhibits human LDL oxidation in vitro. Atherosclerosis 2008, 201, 92-100. http://dx.doi.org/10.1016/j.atherosclerosis.2008.02.030
204. Hort, M.A.; Straliotto, M.R.; Netto, P.M.; da Rocha, J.B.; de Bem, A.F.; Ribeiro-do-Valle, R.M. Diphenyl diselenide effectively reduces atherosclerotic lesion in LDLr-/- mice by attenuation of oxidative stress and inflammation. J. Cardiovasc. Pharmacol. 2011, 58, 91-101. DOI: 10.1097/FJC.0b013e31821d1149
205. de Bem, A.F.; Portella, R.D.; Colpo, E.; Duarte, M.M.M.F.; Frediane A.; Taube, P.S.; Nogueira, C.W.; Farina, M.; da Silva, E.L.; Rocha, J.B.T. Diphenyl diselenide decreases serum levels of total cholesterol and tissue oxidative stress in cholesterol-fed rabbits. Basic Clin. Pharmacol. Toxicol. 2009, 105, 17-23. http://dx.doi.org/10.1111/j.1742-7843.2009.00414.x
206. da Rocha, J.T.; Sperança, A.; Nogueira, C.W.; Zeni, G. Hypolipidaemic activity of orally administered diphenyl diselenide in Triton WR-1339-induced hyperlipidaemia in mice. J. Pharm. Pharmacol. 2009, 61, 1673-1679. http://dx.doi.org/10.1211/jpp/61.12.0013
207. Barbosa, N.B.V.; Rocha, J.B.T.; Wondracek, D.C.; Perottoni, J.; Zeni, G.; Nogueira, C.W. Diphenyl diselenide reduces temporarily hyperglycemia: possible relationship with oxidative stress. Chem. Biol. lnteract. 2006, 163, 230-238. http://dx.doi.org/10.1016/j.cbi.2006.08.004
208. de Vargas Barbosa, N.B.; Nogueira, C.W.; Guecheva, T.N.; Bellinaso, M.D.; Rocha, J.B.T. Diphenyl diselenide supplementation delays the development of N-nitroso-N-methylurea-induced mammary tumors. Arch. Toxicol. 2008, 82, 655-663. http://dx.doi.org/10.1007/s00204-007-0271-9
209. Barbosa, N.B.D.; Oliveira, C.; Araldi, D.; Folmer, V.; Rocha, J.B.T.; Nogueira, C.W. Acute diphenyl diselenide treatment reduces hyperglycemia but does not change delta-aminolevulinate dehydratase activity in alloxan-induced diabetes in rats. Biol. Pharm. Bull. 2008, 31, 2200-2204. http://dx.doi.org/10.1248/bpb.31.2200
210. Vinceti, M.; Maraldi, T.; Bergomi, M.; Malagoli, C. Risk of chronic low-dose selenium overexposure in humans: insights from epidemiology and biochemistry. Rev. Environ. Health 2009, 24, 231-248. PubMed ID: 19891121
211. Stranges, S.; Sieri, S.; Vinceti, M.; Grioni, S.; Guallar, E.; Laclaustra, M.; Muti, P.; Berrino, F.; Krogh, V. A prospective study of dietary selenium intake and risk of type 2 diabetes. BMC Public Health 2010, 10, 564. http://dx.doi.org/10.1186/1471-2458-10-564
212. Saito, I.; Asano, T.; Sano, K.; Takakura, K.; Abe, H.; Yoshimoto, T.; Kikuchi, H.; Ohta, T.; Ishibashi, S. Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery 1998, 42, 269-277. http://dx.doi.org/10.1097/00006123-199802000-00038
213. Johshita, H.; Sasaki, T.; Matsui, T.; Hanamura, T.; Masayasu, H.; Asano, T.; Takakura, K. Effects of ebselen (PZ51) on ischaemic brain oedema after focal ischaemia in cats. Acta Neurochir. Suppl. (Wien) 1990, 51, 239-241. http://dx.doi.org/10.1007/978-3-7091-9115-6_80
214. Takasago, T.; Peters, E.E.; Graham, D.I.; Masayasu, H.; Macrae, I.M. Neuroprotective efficacy of ebselen, an anti-oxidant with antiinflammatory actions, in a rodent model of permanent middle cerebral artery occlusion. Br. J. Pharmacol. 1997, 122, 1251-1256. http://dx.doi.org/10.1038/sj.bjp.0701426
215. Dawson, D.A.; Masayasu, H.; Graham, D.I.; Macrae, I.M. The neuroprotective efficacy of ebselen (a glutathione peroxidase mimic) on brain damage induced by transient focal cerebral ischaemia in the rat. Neurosci. Lett. 1995, 185, 65-69. http://dx.doi.org/10.1016/0304-3940(94)11226-9
216. Sui, H.; Wang, W.; Wang, P.H.; Liu, L.S. Protective effect of antioxidant ebselen (PZ51) on the cerebral cortex of stroke-prone spontaneously hypertensive rats. Hypertens. Res. 2005, 28, 249-254. http://dx.doi.org/10.1291/hypres.28.249
217. Ghisleni, G.; Porciúncula, L.O.; Cimarosti, H.; Rocha, J.B.T.; Salbego, C.G.; Souza, D.O. Diphenyl diselenide protects rat hippocampal slices submitted to oxygen-glucose deprivation and diminishes inducible nitric oxide synthase immunocontent. Brain Res. 2003, 986, 196-199. http://dx.doi.org/10.1016/S0006-8993(03)03193-7
218. Ghisleni, G.; Porciúncula, L.O.; Mioranzza, S.; Boeck, C.R.; Rocha, J.B.T.; Souza, D.O. Selenium compounds counteract the stimulation of ecto-nucleotidase activities in rat cultured cerebellar granule cells: putative correlation with neuroprotective effects. Brain Res. 2008, 1221, 134-140. http://dx.doi.org/10.1016/j.brainres.2008.04.033
219. Sher, L. Selenium and human health. Lancet 2000, 356, 943. http://dx.doi.org/10.1016/S0140-6736(05)73927-1
220. Sher, L. Possible role of selenium deficiency in the neurobiology of depression and suicidal behavior in patients with alcohol use disorders. Int. Disabil. Human Dev. 2007, 6, 227-230. ISSN: 1565012X
221. Rayman, M.P. The importance of selenium to human health. Lancet, 2000, 356, 233-241. http://dx.doi.org/10.1016/S0140-6736(00)02490-9
222. Benton, D. Selenium intake, mood and other aspects of psychological functioning. Nutr. Neurosci. 2002, J, 363-374. http://dx.doi.org/10.1016/0006-3223(91)90251-G
223. Benton, D.; Cook, R. The impact of selenium supplementation on mood. Biol. Psychiatry, 1991, 29, 1092-1098. http://dx.doi.org/10.1016/j.pnpbp.2007.05.006
224. Savegnago, L.; Jesse, C.R.; Pinto, L.G.; Rocha, J.B.T.; Nogueira, C.W.; Zeni, G. Monoaminergic agents modulate antidepressant-like effect caused by diphenyl diselenide in rats. Prog. Neuro-psychopharmacol. Biol. Psychiatry 2007, 31, 1261-1269.PMID: 17590255
225. Acker, C.I.; Luchese, C; Prigol, M.; Nogueira, C.W. Antidepressant-like effect of diphenyl diselenide on rats exposed to malathion: involvement of Na K ATPase activity. Neurosci. Lett., 2009, 455, 168-172. doi: 10.1016/j.neulet.2009.03.069
226. Savegnago, L.; Jesse, C.R.; Pinto, L.G.; Rocha, J.B.T.; Barancelli, D.A.; Nogueira, C.W.; Zeni, G. Diphenyl diselenide exerts antidepressant-like and anxiolytic-like effects in mice: involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway in its antidepressant-like action. Pharmacol. Biochem. Behav. 2008, 88, 418-426.
227. Wilhelm, E.A.; Jesse, C.R.; Bortolatto, C.F.; Barbosa, N.B.V.; Nogueira, C.W. Evidence of the involvement of K channels and PPARy receptors in the antidepressant-like activity of diphenyl diselenide in mice. J. Pharm. Pharmacol. 2010, 62, 1121-1127. doi: 10.1111/j.2042-7158.2010.01132.x
228. Ghisleni, G.; Kazauckas, V.; Both, F.L.; Pagnussat, N.; Mioranzza, S.; Rocha, J.B.T.; Souza, D.O.; Porciúncula, L.O. Diphenyl diselenide exerts anxiolytic-like effect in Wistar rats: putative roles of GABAa and 5HT receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32, 1508-1515. doi: 10.1016/j.pnpbp.2008.05.008
229. Nogueira, C.W.; Rocha, J.B.T. Diphenyl diselenide a janus-faced molecule. J. Braz. Chem. Soc, 2010, 21, 2055-2071. http://www.scielo.br/scielo.php?pid=S0103-50532010001100006&script=sci_abstract
230. Orian, L.; Toppo, S. Organochalcogen peroxidase mimetics as potential drugs: a long story of a promise still unfulfilled. Free Radic. Biol. Med. 2013, 5 (5,65-74. 10.1016/j.freeradbiomed.2013. 03.006